logo
logo
Sign in

Dementia & Alzheimer Disease Market Research and Report 2025

avatar
Diana Rusco
Dementia & Alzheimer Disease Market Research and Report 2025
 dementia & alzheimer disease market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. According to the World Health Organization, cost of treatment of dementia is more than USD 604 billion per year. This includes the cost of providing health and social care as well the reduction or loss of income of people with dementia and their caregivers.
 

Market Definition:

The most common cause of dementia is Alzheimer’s disease. Dementia is a group of co-occurring signs and symptoms that includes progressive worsening of intellectual role.  Dementia defines number of symptoms which contains memory loss and problems with thinking, problem-solving or language. These types of indications generally happen when the brain is injured by particular diseases, counting Alzheimer’s illness Numerous cognitive abilities are reduced with dementia, including language, attention, memory, reasoning, visuospatial function, decision making, orientation and others. People with dementia and cognitive impairments often suffer with change in personality, emotional regulation, and social behaviors. Significantly, the intellectual and behavioral changes occur with dementia that can interfere with work, social activities, relationships and damage a person’s ability to perform routine daily activities (e.g., driving, shopping, housekeeping, cooking, managing finances, and personal care). Common symptoms of dementia include the gradual loss of memory, decline in communication skills and difficulty with thinking and reasoning.
 
NOTE: Our team is studying COVID19 and its impact on various industry verticals and wherever required we will be considering Covid19 footprints for a better analysis of markets and industries. Kindly get in touch for more details.
 
Get Exclusive Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dementia-alzheimer-disease-market
 
Market Drivers and Restraints:
 
Growing prevalence of Alzheimer’s disease
 
Increasing awareness about the treatment of Alzheimer’s disease
 
High treatment cost
 
Side effects of the disease treatment
 
Key Players: Global Dementia & Alzheimer Disease Market
 
Ono Pharmaceutical, Daiichi Sankyo Company Limited, H Lundbeck A/S, Johnson & Johnson, Eisai Co Ltd., Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG, Eisai Co. Ltd., Lundbeck A/S and Teva Pharmaceuticals Industries Ltd., Eli Lilly and Company, TauRx Pharmaceuticals Ltd, VTV Therapeutics, Hoffman-La Roche Ltd., AstraZeneca plc, and AC Immune
 
MAJOR TOC OF THE REPORT
 
Chapter One: Dementia & Alzheimer Disease Market Overview
 
Chapter Two: Manufacturers Profiles
 
Chapter Three: Global Dementia & Alzheimer Disease Market Competition, by Players
 
Chapter Four: Global Dementia & Alzheimer Disease Market Size by Regions
 
Chapter Five: Global Dementia & Alzheimer Disease Market Revenue by Countries
 
Chapter Six: Global Dementia & Alzheimer Disease Market Revenue by Drug Class
 
Chapter Seven: Global Dementia & Alzheimer Disease Market Revenue by  Distribution Channel
 
Chapter Eight: Global Dementia & Alzheimer Disease Market Revenue by Geography
 
 
Key Developments in the Market
In January 2018, Dthera Sciences (U.S.), launched ReminX, which is an artificial-intelligence-powered consumer health product designed to digitally deliver reminiscence therapy to individuals suffering from Alzheimer's and other dementias.
 
In July 2018, ADI (U.S.) and Global Coalition on Aging (GCOA) (U.S.) launched the Dementia Innovation Readiness Index during ADI’s 33rd International Conference in Chicago. This Index can be used to analyze the readiness of countries to develop and organize dementia solutions into their healthcare, policy and social frameworks.
 
Primary Respondents:
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others
Key Questions Answered in Report:
 
What is the key to the Dementia & Alzheimer Disease Market?
 
What will the Dementia & Alzheimer Disease Market Demand and what will be Growth?
 
What are the latest opportunities for Dementia & Alzheimer Disease Market in the future?
 
What are the strengths of the key players?
 
 
NOTE: Our team is studying COVID19 and its impact on various industry verticals and wherever required we will be considering Covid19 footprints for a better analysis of markets and industries. Kindly get in touch for more details.
 
About Us:
 
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
 
Contact:
 
Data Bridge Market Research
 
Tel: +1-888-387-2818
 
 
Browse Related Reports@
 
 
 
 
 
 
 
collect
0
avatar
Diana Rusco
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more